Whitehawk Therapeutics, Inc. (WHWK) Operating income 2016–2025
Whitehawk Therapeutics, Inc. (WHWK) annual operating income history from SEC filings — each fiscal year as reported.
-$114.4MFY2025 · since FY2016: -$16.6M → -$114.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$114.4M | -69.6% |
| FY2024 | -$67.5M | +6.2% |
| FY2023 | -$71.9M | -14.8% |
| FY2022 | -$62.7M | +43.6% |
| FY2021 | -$111.2M | -4263.2% |
| FY2020 | -$2.5M | +89.6% |
| FY2019 | -$24.4M | -118.6% |
| FY2018 | -$11.2M | +47.7% |
| FY2017 | -$21.4M | -28.6% |
| FY2016 | -$16.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice